Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance

DLocal targets 60%–70% TPV growth and 25%–30% gross profit growth in 2026 as operating leverage is expected to improve

France inflation accelerates to 2.1% in July

Charter-Cox merger gets final state approval

Dentsu GAAP EPS of ¥177.58, revenue of ¥717.35B; reaffirms FY 2026 outlook